News & Events

At Bio-IT World 2026, Chris Waller, PhD, presented “The Lab of the Present: Lowering the Barriers to Scientific Innovation with Quantori's Q-Suite Accelerators,” a compelling look at how agentic AI is reshaping life sciences R&D today.

Key Highlights

The Productivity Paradox

Despite unprecedented investment in biopharma, labs remain stuck in manual bottlenecks. Scientists spend 40% of their time on repetitive tasks, while data stays trapped in fragmented ELNs/LIMS and AI models suffer from explainability and reproducibility issues.

Introducing Q-Suite™

Quantori's modular, agentic AI platform addresses these challenges end-to-end, spanning drug discovery (Q-Discover), data unification (Q-Data), HPC compute (Q-HPC), scientific workflows (Q-Scientist), and secure enterprise AI adoption (Q-Portal).

Agentic AI: From Tools to Collaborators

Unlike passive software, agentic AI autonomously reasons, plans, and decomposes high-level scientific goals, such as “Optimize this lead for better ADMET,” into actionable instructions for both digital and robotic systems.

Self-Optimizing DMTA Cycle

Q-Suite powers a fully automated Design → Make → Test → Analyze loop, compressing drug discovery timelines from months to days.

Safety by Design

To prevent unconstrained AI autonomy, Quantori introduced the Q-Scientist Actions Graph, a knowledge graph-based semantic guardrail that enforces the laws of chemistry and biology, ensuring all AI-suggested actions are physically possible and safe.

Standardizing with MCP

The Model Context Protocol (MCP) solves the “NxM” integration problem, enabling AI agents to securely connect with LIMS, EHRs, and enterprise systems without custom code.

Beyond Discovery

Agentic capabilities extend into CMC (Chemistry, Manufacturing & Controls), with specialized agents for process optimization, tech transfer, and automated regulatory filing drafting (FDA/EMA Module 3).

A Thought-Provoking Close

Chris wrapped up with a timely caution: “We are creating new silicon-based life forms and don't have the ethical guidelines in place for the treatment of these new creatures,” reminding us that excitement about new technology must be matched with scientific rigor and ethical foresight.

Thank you to everyone who joined the talk. If you missed it, you can download the slides here.